Selected article for: "cc NC ND International license and infectious person"

Author: Lucia Russo; Cleo Anastassopoulou; Athanassios Tsakris; Gennaro Nicola Bifulco; Emilio Fortunato Campana; Gerardo Toraldo; Constantinos Siettos
Title: Tracing DAY-ZERO and Forecasting the Fade out of the COVID-19 Outbreak in Lombardy, Italy: A Compartmental Modelling and Numerical Optimization Approach.
  • Document date: 2020_3_20
  • ID: fuqtwn5a_23
    Snippet: In particular, in many studies that use SEIRD models, the parameter σ is set equal to the inverse of the mean incubation period (time from exposure to the development of symptoms) of a virus. However, the incubation period does not generally coincide with the time from exposure to the time that someone starts 140 to be infectious. Regarding COVID-19, it has been suggested that an exposed person can be infectious well before the development of sy.....
    Document: In particular, in many studies that use SEIRD models, the parameter σ is set equal to the inverse of the mean incubation period (time from exposure to the development of symptoms) of a virus. However, the incubation period does not generally coincide with the time from exposure to the time that someone starts 140 to be infectious. Regarding COVID-19, it has been suggested that an exposed person can be infectious well before the development of symptoms [16] . With respect to the incubation period for SARS-CoV-2, a study in China [17] suggests that it may range from 2-14 days, with a median of 5.2 days. Another study in China, using data from 1,099 patients with laboratory-confirmed 2019-nCoV 145 ARD from 552 hospitals in 31 provinces/provincial municipalities suggested 8 . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • cc NC ND International license and day median: 1
    • cc NC ND International license and exposure time: 1, 2, 3, 4, 5, 6, 7
    • cc NC ND International license and incubation period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and mean incubation period: 1, 2, 3, 4, 5
    • cc NC ND International license and SARS incubation period: 1, 2, 3, 4
    • cc NC ND International license and SEIRD model: 1
    • China study and day median: 1, 2, 3
    • China study and exposure time: 1, 2, 3, 4, 5, 6
    • China study and incubation period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • China study and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • China study and SARS incubation period: 1
    • China study and SEIRD model: 1, 2
    • China study and symptom development: 1
    • day median and exposure time: 1, 2, 3, 4, 5, 6, 7, 8
    • day median and incubation period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • day median and International license: 1
    • day median and mean incubation period: 1, 2, 3
    • day median and SARS incubation period: 1, 2